Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults
Journal of the American College of Cardiology · 2023-05 · 81 (20) · 2028-2039
DOI: 10.1016/j.jacc.2023.03.403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2023-05. Verfasst von John W McEvoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology and National Institute for Prevention and Cardiovascular Health, University of Galway, Galway, Ireland; Johns Hopkins School o…. Hauptthemen laut MEDLINE: Troponin T, Troponin I. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Myocardial injury is currently defined as a cardiac troponin above the sex-specific 99th percentile of a healthy reference population (upper reference limit [URL]). OBJECTIVES: The purpose of this study was to estimate high-sensitivity (hs) troponin URLs in a representative sample of the U.S. adult population; overall and by sex, race/ethnicity, and age group. METHODS: Among adults participating in the 1999-2004 National Health and Nutrition Examination Survey (NHANES), we measured hs-troponin T using 1 assay (Roche) and hs-troponin I using 3 assays (Abbott, Siemens, and Ortho). In a strictly defined healthy reference subgroup, we estimated 99th percentile URLs for each assay using the recommended nonparametric method. RESULTS: Of 12,545 participants, 2,746 met criteria for the healthy subgroup (mean age 37 years, 50% men). The NHANES 99th percentile URL for hs-troponin T (19 ng/L) matched the manufacturer-reported URL (19 ng/L). NHANES URLs were 13 ng/L (95% CI: 10-15 ng/L) for Abbott hs-troponin I (manufacturer: 28 ng/L), 5 ng/L (95% CI: 4-7 ng/L) for Ortho hs-troponin I (manufacturer: 11 ng/L), and 37 ng/L (95% CI: 27-66 ng/L) for Siemens hs-troponin I (manufacturer: 46.5 ng/L). There were significant differences in URLs by sex, but none by race/ethnicity. Furthermore, the 99th percentile URLs for all 4 hs-troponin assays were statistically significantly lower in healthy adults aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology and National Institute for Prevention and Cardiovascular Health, University of Galway, Galway, Ireland; Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Depart…
- Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School o…
- Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
McEvoy, J. W., Tang, O., Wang, D., Ndumele, C. E., Coresh, J., Christenson, R. H., & Selvin, E. (2023). Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults. Journal of the American College of Cardiology, 81(20), 2028-2039. https://doi.org/10.1016/j.jacc.2023.03.403
Vancouver
McEvoy JW, Tang O, Wang D, Ndumele CE, Coresh J, Christenson RH, et al. Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults. Journal of the American College of Cardiology. 2023;81(20):2028-2039. doi:10.1016/j.jacc.2023.03.403
BibTeX
@article{McEvoy2023,
author = {McEvoy, John W and Tang, Olive and Wang, Dan and Ndumele, Chiadi E and Coresh, Josef and Christenson, Robert H and Selvin, Elizabeth},
title = {Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults},
journal = {Journal of the American College of Cardiology},
year = {2023},
volume = {81},
number = {20},
pages = {2028--2039},
doi = {10.1016/j.jacc.2023.03.403}
}
EUVIMED